ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korppi, M.
Right arrow Articles by Remes, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korppi, M.
Right arrow Articles by Remes, S.
Eur Respir J 2001; 17:623-627
Copyright ©ERS Journals Ltd 2001


Serum procalcitonin in pneumococcal pneumonia in children

M. Korppi and S. Remes

Dept of Paediatrics, Kuopio University Hospital, Finland

CORRESPONDENCE: M. Korppi, Dept of Paediatrics, Kuopio University Hospital, FIN-70210, Kuopio, Finland. Fax: 35 817172410

Keywords: children, enzyme immunoassay, pneumonia, pneumococcus, procalcitonin, serology

Received: February 21, 2000
Accepted December 12, 2000

Serum procalcitonin (PCT), a marker of bacterial infection, was measured in children with pneumonia to examine whether PCT can be used to screen pneumococcal (PNC) from viral pneumonia.

The number of patients was 132; mean age 3.0 yrs, and 64% were males. In all cases, pneumonia was radiologically confirmed, being alveolar in 46 and interstitial in 86 cases. The aetiology of infection was studied by a panel of serological tests for PNC, for five other respiratory bacteria and for seven common respiratory viruses. PNC infection was found in 25, mixed viral-PNC infections in 13 and viral infection in 17 cases.

In general, serum PCT was not associated with the type or aetiology of pneumonia. PCT values were >1.0 mg·L–1 in 40% of PNC cases, as compared to 12–15% in viral or mixed cases, respectively (p<0.05). PCT values were significantly higher in >2 yrs old children than in younger ones. The cut-off limits of 0.5 ng·mL–1, 1.0 ng·mL–1and 2.0 ng·mL–1 were tested for screening between PNC and viral pneumonia. The highest sensitivity of 55% was found at the 0.5 ng·mL–1 cut-off level, whereas the highest specificity of 88% was reached at the level of 1.0 ng·mL–1. The likelihood ratios, however, were far from optimal for both the positive and negative results.

Although marginally higher in pneumococcal pneumonia than in viral pneumonia, serum procalcitonin cannot be used to discriminate between these two types of pneumonia.




This article has been cited by other articles:


Home page
ThoraxHome page
I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, and on behalf of the Paediatric Pleural Diseases Subco
BTS guidelines for the management of pleural infection in children
Thorax, February 1, 2005; 60(suppl_1): i1 - i21.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.